Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Correction: Imatinib Ameliorates Neuroinflammation in a Rat Model of Multiple Sclerosis by Enhancing Blood-Brain Barrier Integrity and by Modulating the Peripheral Immune Response.
Recessively transmitted predominantly motor neuropathies.
Re. 'Doppler Ultrasound Examination of Multiple Sclerosis Patients and Control Participants: Inter-observer Agreement and Association with Disease'
[Molecular targeted therapy for neuroimmunological diseases].
Efficacy and safety of alemtuzumab in multiple sclerosis and impact on nursing role.
Cerebrospinal fluid lactate is associated with multiple sclerosis disease progression.
Laquinimod in the treatment of multiple sclerosis: a review of the data so far.
Pain and Cognition in Multiple Sclerosis.
Multiple sclerosis: evaluation of purine nucleotide metabolism in central nervous system in association with serum levels of selected fat-soluble antioxidants.
Sex drive and sexual desire.
The azetidine derivative, KHG26792 protects against ATP-induced activation of NFAT and MAPK pathways through P2X7 receptor in microglia.
Remyelination in multiple sclerosis: realizing a long-standing challenge.
Relationship between gait initiation and disability in individuals affected by multiple sclerosis.
T1- Thresholds in Black Holes Increase Clinical-Radiological Correlation in Multiple Sclerosis Patients.
Meningeal inflammation in multiple sclerosis: The key to the origin of cortical lesions?
Neuroinflammatory signals enhance the immunomodulatory and neuroprotective properties of multipotent adult progenitor cells.
A role for HLA-DRB1*1101 and DRB1*0801 in cognitive ability and its decline with age.
Multiple sclerosis in India: An overview.
A spring to summer shift of pro-inflammatory cytokine production in multiple sclerosis patients.
Reduction in serum aquaporin-4 antibody titers during development of a tumor-like brain lesion in a patient with neuromyelitis optica: a serum antibody-consuming effect?
Inhibition of System Xc- Transporter Attenuates Autoimmune Inflammatory Demyelination.
Mental Health in Multiple Sclerosis Patients without Limitation of Physical Function: The Role of Physical Activity.
Mesenchymal stem cells require the peripheral immune system for immunomodulating effects in animal models of multiple sclerosis.
CRYAB-650 C>G (rs2234702) affects susceptibility to Type 1 diabetes and IAA-positivity in Swedish population.
Kinetics of IL-6 production defines T effector cell responsiveness to regulatory T cells in multiple sclerosis.
Pages
« first
‹ previous
…
576
577
578
579
580
581
582
583
584
…
next ›
last »